Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Makuch

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
JAMA|April 27, 1979
Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancerM H Cohen, P B Chretien, D C Ihde, et al.
Bulletin Du Cancer|January 1, 1982
Experience of the National Cancer Institute (USA) in the treatment and biology of small cell lung cancerJ D Minna, P A Bunn, D N Carney, et al.
JAMA|September 9, 2000
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyF E Silverstein, G Faich, J L Goldstein, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
JAMA|April 27, 1979
Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancerM H Cohen, P B Chretien, D C Ihde, et al.
Bulletin Du Cancer|January 1, 1982
Experience of the National Cancer Institute (USA) in the treatment and biology of small cell lung cancerJ D Minna, P A Bunn, D N Carney, et al.
JAMA|September 9, 2000
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyF E Silverstein, G Faich, J L Goldstein, et al.
Pageof 7